Information updates

Changes to adrenaline autoinjector labels

Apr 19 2016: 

In Australia, adrenaline is the approved name of the ingredient in autoinjector devices used for the emergency treatment of anaphylaxis. Currently, the only available autoinjector to treat anaphylaxis in Australia and New Zealand is supplied under the brand name EpiPen®. In some countries, including the USA, adrenaline is known as epinephrine.

During 2016 adrenaline autoinjector labels in Australia will start to show 'adrenaline (epinephrine)' as the ingredient name. Including both names on Australian medicines should help make it clear that these are the same ingredient, and reduce confusion for Australians travelling overseas, visitors to Australia and health professionals trained internationally.

ASCIA will gradually update all of its anaphylaxis resources over the next two years to also show 'adrenaline (epinephrine)' as communicated in the April 2016 issue of ASCIA News Update www.allergy.org.au/about-ascia/updates 

ASCIA anaphylaxis resources include action plans and e-training courses. These are available open access from the ASCIA website:
www.allergy.org.au/health-professionals/anaphylaxis-resources 
www.allergy.org.au/about-ascia/about-ascia-e-training 
www.allergy.org.au/schools-childcare 

For further information about changes to adrenaline labels visit www.tga.gov.au/changes-adrenaline-and-noradrenaline-labels 

For information about the 1st National Allergy Strategy for Australia visit www.nationalallergystrategy.org.au 

To donate to allergy and immunology research visit www.allergyimmunology.org.au 

Mod ASCIA Member
Donate to AIFA
go to NAS website
Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect
This website is certified by Health On the Net Foundation. Click to verify.This site complies with the HONcode standard for trustworthy health information.Verify here.